Shire PLC (SHPG) Shares Purchased by Columbia Partners L C Investment Management



[ad_1]

  Shire logo "title =" Shire logo "clbad =" companylogo "/> Columbia Partners LLC Investment Management increased its holdings of Shire PLC (NASDAQ: SHPG) shares by 39.1% in the second quarter, according to The company in its most recent publication with the Securities and Exchange Commission (SEC) The institutional investor held 30,203 shares of the biopharmaceutical company after purchasing 8,495 additional shares during the quarter. LLC Investment Management in Shire was worth $ 5,098,000 as of the most recent SEC filing date. </p>
<p>  Several other major investors also made changes to their positions in SHPG. Shire in the fourth quarter valued at about $ 116,000 Sawtooth Solutions LLC bought a new position in Shire in the fourth quarter of approximately $ 200,000 Resources Investment Advisors Inc. raised its holdings in Shire by 70.2 In the first quarter, Resources Investment Advisors Inc. now holds 1,540 shares of the biopharmaceutical company valued at $ 230,000 after acquiring 635 additional shares during the period. United Bank bought a new position in Shire in the first quarter, valued at approximately $ 245,000. Finally, Shepherd Kaplan Krochuk LLC purchased a new position in Shire in the first quarter, valued at approximately $ 254,000. 17.92% of the stock is currently held by hedge funds and other institutional investors. </p>
<p>  SHPG traded up $ 0.19 in mid-day Thursday, reaching $ 172.30. The company had a trading volume of 17,221 shares, compared to its average volume of 880,386. The company has a fast ratio of 0.66, a ratio of 1.14 and a debt ratio of 0.45. The stock has a market capitalization of $ 52.60 billion, a price / earnings ratio of 11.33, a PEG ratio of 1.43 and a beta of 1.28. Shire PLC has an annual low of $ 123.73 and a high of $ 177.51. </p>
<p>  Shire (NASDAQ: SHPG) released its quarterly results on Thursday, April 26. The biopharmaceutical company reported earnings per share of $ 3.86 for the quarter, exceeding consensus badyst estimates of $ 3.58 per $ 0.28. The company achieved a turnover of $ 3.77 billion during the quarter. Shire had a return on equity of 13.60% and a net margin of 28.96%. The quarterly business turnover of the company increased by 5.4% compared to the same quarter of last year. In the same quarter of the previous year, the company earned $ 3.63 per share. Stock badysts predict that Shire PLC will post 15.27 earnings per share for the current fiscal year. </p>
<p>  A number of research badysts have weighed on the company. BidaskClub shifted Shire from a "sell" note to a "keep" note in a report on Tuesday, July 3rd. Kepler Capital Markets has reissued a buy note on Shire shares in a report on Friday, May 11th. BTIG Research reissued a buy note and issued a $ 195.00 target price on Shire shares in a report on Sunday, April 29th. Royal Bank of Canada reissued a "buy" note on Shire shares in a report on Tuesday, May 8. Finally, B. Riley increased his target price on Shire to $ 200 and gave the company a "buy" rating in a report on Thursday, April 19th. An badyst rated the stock with a sales note, seven badigned a reserve rating and twelve awarded a purchase note to the company's stock. The company currently has an average rating of "Buy" and a consensus price target of $ 201.64 </p>
<p>  <strong> Shire Company Profile </strong> </p>
<p>  Shire plc, a biotechnology company, researches, develops, licenses manufactures, markets, distributes and sells medicines for rare diseases and other specialized conditions worldwide. The company offers products in therapeutic areas, including hematology, genetic diseases, neuroscience, immunology, internal medicine, ophthalmology and oncology <!--ViewCount:ArticleHistoryID=21304454&PostDate=2018-7-12&type=f&id=3709066--></p>
<p style=  Institutional Ownership by Quarter for Shire (NASDAQ: SHPG)

Receive news and ratings of Shire Daily – Enter your email address below to receive a concise summary of the latest news and badyst ratings for Shire and related companies with MarketBeat.com FREE Daily Electronic Newsletter.

[ad_2]
Source link